Efficacy of ground flaxseed on constipation in patients with irritable bowel syndrome

Current Topics in Nutraceutical Research

Volumn 2, Issue 2, 2004, Pages 119-125

  Tarpila, Simo ^a,f   Tarpila, A ^b   Grohn P ^c   Silvennoinen, T ^d   Lindberg, L ^e  

^a Mehilainen Oy   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c MEDI METRO   (Finland)

^d Occupational Health   (Finland)

^e Aleksi Medical Center   (Finland)

^f NONE   (Finland)

Author keywords

Constipation; Flaxseed; Irritable bowel syndrome; Thiocynate

Indexed keywords

BETA GLUCAN; CADMIUM; ISPAGULA; LINOLEIC ACID; LINOLENIC ACID; LINSEED EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PLANT EXTRACT; PROTEIN; THIOCYANATE; UNCLASSIFIED DRUG; VISIBLIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CHEMICAL COMPOSITION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE ULCER; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 2442481460     PISSN: 15407535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Adlercreutz, H. and Mazur, W. (1997) Phytoestrogens and western diseases. Annales Medicine 29, 95-120.
2. Adlercreutz, H. (2002) Phyto-oestrogens and cancer. The Lancet Oncology 3, 364-373.
3. American Conference of Governmental Industrial Hygienists (ACGIH). 1994-1995 Treshold limit values for chemical substances and physical agents and biological exposure indices. Cincinati, OH, USA; ACGIH, 1994.
4. Cann, P.A., Read, N.W. and Holdsworth, C.D. (1984) What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 24:168-173.
5. Connor, W.E. (1999) α-linolenic acid in health and disease. American Journal of Clinical Nutrition 69, 827-828.
6. Cunnane, S.C., Hamadeh, M.J.m Liede, A.C., Thompson, L.U. and Wolever, T.M.S. (1995) Nutritional attributes of traditional flaxseed in healthy young adults. American Journal of Clinical Nutrition 61, 62-68.
7. Hu, F.B., Stampfer, M.J., Manson, J.E., Rimm, E.B., Wolk, A., Colditz, G.A., Hennekens, C.H. and Willett, W.C. (1999). Dietary intake of μ-linolenic acid and risk of fatal ischemic heart disease among women. American Journal of Clinical Nutrition 69, 890-897.
8. Jenkins, D.J.A., Kendall, C.W.C., Vidgen, E., Agarwal, S., Rao, A.V., Rosenberg, R.S., Diamandis, E.P., Novokmet, R., Mehling, C.C., Perera, T., Griffin, L.C. and Cunnane, S.C. (1999). Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures and ex vivo androgen and progestin activity: a controlled crossover trial. American Journal of Clinical Nutrition 69,395-402.
9. Kiilunen, M. and Aitio, A. (1990). Diluting and mild ashing techniques for the routine determination of cadmium in blood and urine. In: International symposium on trace elements in health and disease. 5.-8.7. 1990 Espoo. Abstracts. Helsinki: Institute of Occupational Health, 1990:86.
10. Kumar, A., Kumar, N. and Vij, J.C.(1987). Optimum dosage of isphagula husk in patients with irritable bowel syndrome - correlation of symptom relief with whole gut transit time and stool weight. Gut 28,150-155.
11. Lundquist P, Kågedal B. and Nilsson L (1995). An improved method for determination of thiocyanate in plasma and urine. European Journal of Clinical Chemistry & Clinical Biochemistry 33,343-349.
12. Manning, A.P., Heaton, K.W., Harvey, R.F. and Uglow, P. (1977). Wheat fiber and irritable bowel syndrome. Lancet 1,417-418.
13. Nordic Nutrition recommendations (1996). Scandinavian Journal of Nutrition 40, 161-165.
14. Prior, A. and Whorwell, P.J. (1987). Double blind study of isphagula in the irritable bowel syndrome. Gut 28, 1510-1513.
15. Tarpila, S., Aro, A., Salminen, I., Tarpila, A., Kleemola, P., Akkila, J. and Adlercreutz, H. (2002) The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone. European Journal of Clinical Nutrition 56, 157-165.